Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of IVL3003 vs Aricept in Healthy Subjects
NCT05345509Phase 2Active, not recruiting
- Sponsor
- Inventage Lab
- Start
- Apr 2023
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of WIL-1901 in Alzheimer's disease (AD), sponsored by Inventage Lab. Started Apr 2023; status: active, not recruiting.
02
Drugs
WIL-1901
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT05345509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05345509.